SMi Source Lesson Diabetes: Introduction to Incretin

  • SMi Source lesson Diabetes: Introduction to Incretin has the following microlearning topics

    • 1. Incretins and Incretin-based Therapies

    2. Introduction to Incretin: Learning Objectives

    3. Incretins and the Incretin Effect

    4. GLP-1 and GIP Actions

    5. Glucose Only, GLP-1 Only, GLP-1 + Glucose

    6. Other GLP-1 Effects on Beta Cell Function and Mass

    7. Knowledge Check: Incretins

    8. Knowledge Check: The Incretin Effect

    9. The Incretin Effect

    10. Effects of GLP-1 Therapy

    11. Incretin-based Therapies in Diabetes

    12. Knowledge Check: Incretin Therapy

    13. Overview of GLP-1 Receptor Agonists

    14. GLP-1 Receptor Agonists: Increasing Duration of Action

    15. Devices Developed for the Delivery of GLP-1 Receptor Agonists

    16. Comparison of GLP-1 Receptor Agonists

    17. Comparative Efficacy of GLP-1 Receptor Agonists

    18. Efficacy of Liraglutide for Weight Loss Among Patients with Type 2 Diabetes

    19. GLP-1 Receptor Agonists: Effect of on Cardiovascular Events

    20. GLP-1 Receptor Agonists: Common Adverse Events with Exenatide

    21. GLP-1 Receptor Agonists: Desirable Characteristics

    22. Marketed DPP-4 Inhibitors

    23. Efficacy of DPP-4 Inhibitors

    24. Safety and Tolerability of DPP-4 Inhibitors

    25. Comparison of GLP-1 Receptor Agonists and DPP-4 Inhibitors

    26. Use in Specific Populations: GLP-1 Receptor Agonists and DPP-4 Inhibitors

    27. Cancer and Pancreatitis

    28. Overview: Benefits and Risks of Incretin-Based Medications

    29. ADA/EASD Treatment Recommendations for People with Type 2 Diabetes

    30. Liraglutide, AWARD-4, GLP-1 receptor agonists

    31. AWARD-5

    32. Knowledge Check: Metformin Add-on

    33. Knowledge Check: Metformin Add-on

  • Lesson Diabetes: Introduction to Incretin teaches these concepts

    • Introduction to Incretin, Incretins and Incretin-based Therapies

  • Lesson Diabetes: Introduction to Incretin addresses these key points

    • Incretins

    • Released from gastrointestinal tract
    • Act on pancreatic β-cells
    • Other actions that influence blood glucose
    • Glucagon-like peptide-1: GLP-1
    • Glucose-dependent insulinotropic polypeptide: GIP

    Incretin-based therapies for T2DM

    • GLP-1 receptor agonists
    • DPP-4 inhibitors

  • Lesson Diabetes: Introduction to Incretin introduces and defines these terms

    • Incretins: Hormones produced by the gastrointestinal tract.